What I do at MMV:
I’m responsible for the late stage portfolio of molecules with demonstrated antimalarial activity and bringing them to first stringent regulatory authority approval. My teams works in partnership with pharmaceutical organizations. We bring together clinical results, appropriate formulations, and all other requirements for successful product development utilizing a cross-functional team approach.
Why I work at MMV:
We know that “it takes a village to raise a drug”. MMV was founded on the principle that a well integrated network of pharmaceutical industry partners, global health agencies, public and private donors will be needed to get the job done. It is fascinating to see that a small office in Geneva can reach out across the world to do just that.
More about me:
Prior to joining MMV in 2012, I was the Head of Global Product Unit for Autoimmune and Inflammatory therapeutic area at Merck Serono in Geneva. I started my career in Discovery Research at Abbott Laboratories in Chicago in Metabolic Disease area. In total, I have more than 15 years of global pharmaceutical industry experience across all phases of drug development. I hold a PhD degree in biochemistry from the University of Illinois, and a Bachelor’s degree in chemistry from the University of Chicago.
Ask me about:
Leading a group of experienced professional drug developers motivated by the gaping need for 21st century medicines to treat malaria in endemic countries.